help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology, doi:10.1210/me.2003-0487
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Figures
Right arrow All Versions of this Article:
18/6/1486    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bisello, A.
Right arrow Articles by Ferrari, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bisello, A.
Right arrow Articles by Ferrari, S. L.
Molecular Endocrinology 18 (6): 1486-1498
Copyright © 2004 by The Endocrine Society

Agonist-Specific Regulation of Parathyroid Hormone (PTH) Receptor Type 2 Activity: Structural and Functional Analysis of PTH- and Tuberoinfundibular Peptide (TIP) 39-Stimulated Desensitization and Internalization

Alessandro Bisello, Danielle Manen, Dominique D. Pierroz, Ted B. Usdin, René Rizzoli and Serge L. Ferrari

Division of Endocrinology and Metabolism (A.B.), Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15261; Division of Bone Diseases (D.M., D.D.P., R.R., S.L.F.), Department of Rehabilitation and Geriatrics, Geneva University Hospital, 1211 Geneva, Switzerland; and Laboratory of Genetics (T.B.U.), National Institute of Mental Health, Bethesda, Maryland 20892

Address all correspondence and requests for reprints to: Serge L. Ferrari, Division of Bone Diseases, Department of Rehabilitation and Geriatrics, Geneva University Hospital, 24 rue Micheli-du-Crest, CH-1211 Geneva 14, Switzerland. E-mail: serge.ferrari{at}medecine.unige.ch.

The human PTH receptor type 2 (PTH2R) is activated by PTH and tuberoinfundibular peptide of 39 residues (TIP39), resulting in cAMP and intracellular Ca signaling. We now report that, despite these similarities, PTH and TIP39 elicit distinct responses from PTH2R. First, TIP39 induced ß-arrestin and protein kinase Cß mobilization and receptor internalization, whereas PTH did not. However, PTH stimulated trafficking of these molecules for a chimeric PTH2R containing the N terminus and third extracellular loop of PTH receptor type 1 (PTH1R). Second, whereas PTH-stimulated cAMP activity was brief and rapidly resensitized, the response to TIP39 was sustained and partly desensitized for a prolonged period. PTH2R desensitization was mediated by ß-arrestin interaction with the C terminus (amino acids 426–457) of PTH2R, whereas ß-arrestin mobilization had a minor influence on PTH2R internalization in response to TIP39, as shown with C terminus deletion mutants and/or dominant negative forms of ß-arrestin and dynamin. These data contrast with PTH1R, at which these dominant negative mutants markedly inhibited receptor internalization. Collectively, these results further highlight how specific interactions within the ligand-receptor bimolecular complex mediate distinct postactivation responses of class II G protein- coupled receptors and provide novel insights into the physiological regulation of PTH2R activity.




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
R. Jorgensen, V. Kubale, M. Vrecl, T. W. Schwartz, and C. E. Elling
Oxyntomodulin Differentially Affects Glucagon-Like Peptide-1 Receptor beta-Arrestin Recruitment and Signaling through G{alpha}
J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 148 - 154.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Rey, D. Manen, R. Rizzoli, J. Caverzasio, and S. L. Ferrari
Proline-rich Motifs in the Parathyroid Hormone (PTH)/PTH-related Protein Receptor C Terminus Mediate Scaffolding of c-Src with beta-Arrestin2 for ERK1/2 Activation
J. Biol. Chem., December 15, 2006; 281(50): 38181 - 38188.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
R. Jorgensen, L. Martini, T. W. Schwartz, and C. E. Elling
Characterization of Glucagon-Like Peptide-1 Receptor {beta}-Arrestin 2 Interaction: A High-Affinity Receptor Phenotype
Mol. Endocrinol., March 1, 2005; 19(3): 812 - 823.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society